ICU Medical, Inc. (NASDAQ:ICUI) Short Interest Down 10.7% in November

ICU Medical, Inc. (NASDAQ:ICUI) saw a significant decline in short interest during the month of November. As of November 15th, there was short interest totalling 582,400 shares, a decline of 10.7% from the October 31st total of 652,500 shares. Approximately 2.6% of the company’s shares are short sold. Based on an average trading volume of 257,300 shares, the days-to-cover ratio is currently 2.3 days.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on ICUI. Raymond James boosted their target price on ICU Medical from $158.00 to $190.00 and gave the company an “outperform” rating in a research note on Thursday, September 12th. Jefferies Financial Group began coverage on ICU Medical in a research note on Monday, October 14th. They issued a “hold” rating and a $183.00 target price for the company. Needham & Company LLC reissued a “hold” rating on shares of ICU Medical in a research note on Wednesday, November 13th. StockNews.com raised ICU Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, November 20th. Finally, KeyCorp upped their price objective on ICU Medical from $198.00 to $209.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 13th. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $173.00.

Insider Transactions at ICU Medical

In related news, COO Christian B. Voigtlander sold 1,962 shares of ICU Medical stock in a transaction on Monday, November 25th. The stock was sold at an average price of $169.08, for a total transaction of $331,734.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Vivek Jain sold 12,000 shares of the business’s stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $162.91, for a total value of $1,954,920.00. Following the completion of the transaction, the chief executive officer now directly owns 104,593 shares of the company’s stock, valued at approximately $17,039,245.63. The trade was a 10.29 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 52,364 shares of company stock worth $8,831,398 over the last 90 days. 6.70% of the stock is owned by insiders.

Institutional Trading of ICU Medical

Several institutional investors and hedge funds have recently bought and sold shares of ICUI. Innealta Capital LLC bought a new stake in ICU Medical during the second quarter worth about $32,000. Hexagon Capital Partners LLC raised its holdings in ICU Medical by 162.7% during the third quarter. Hexagon Capital Partners LLC now owns 197 shares of the medical instruments supplier’s stock worth $36,000 after acquiring an additional 122 shares in the last quarter. Allworth Financial LP raised its holdings in ICU Medical by 100.0% during the third quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier’s stock worth $36,000 after acquiring an additional 100 shares in the last quarter. Russell Investments Group Ltd. raised its holdings in ICU Medical by 46.4% during the first quarter. Russell Investments Group Ltd. now owns 546 shares of the medical instruments supplier’s stock worth $59,000 after acquiring an additional 173 shares in the last quarter. Finally, Venturi Wealth Management LLC raised its holdings in ICU Medical by 1,510.0% during the third quarter. Venturi Wealth Management LLC now owns 322 shares of the medical instruments supplier’s stock worth $59,000 after acquiring an additional 302 shares in the last quarter. Institutional investors own 96.10% of the company’s stock.

ICU Medical Stock Down 1.8 %

Shares of ICUI stock traded down $3.00 on Monday, hitting $160.96. 233,974 shares of the stock were exchanged, compared to its average volume of 273,983. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75. The firm has a market capitalization of $3.94 billion, a P/E ratio of -36.42 and a beta of 0.66. The business has a 50-day moving average of $174.60 and a 200 day moving average of $147.67. ICU Medical has a fifty-two week low of $83.26 and a fifty-two week high of $196.26.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.